 | | Advertisement |  | Frontiers helps you make the most of your valuable professional network through our unique research network. Connect to colleagues, increase your impact and benefit from a 30% increase in downloads of any publication you link to your profile.
Register today |  | |  | | |
TABLE OF CONTENTS
|  |  |  | Volume 17, Issue 1 (March 2014) |  | In this issue Reviews Original Articles Corrigendum Erratum
Also new    AOP
| |  |  |  | | Advertisement |  | 
Try the new prostate cancer crossword puzzle
What are the two glands that sit on top of the kidneys? What is the substance made by the prostate? What is the acronym referring to the stomach and the intestines? Check out the new prostate cancer crossword puzzle from PCAN. You could even win three months of free access to the site.
Click to get started on the crossword. | | |  | | | Reviews | Top |  | Robotic-assisted simple prostatectomy: a systematic review and report of a single institution case seriesP Banapour, N Patel, C J Kane, S A Cohen and J K Parsons Prostate Cancer Prostatic Dis 2014 17: 1-5; advance online publication, December 10, 2013; 10.1038/pcan.2013.52 Abstract | Full Text |  | Original Articles | Top |  | Statin use and incident prostate cancer risk: does the statin brand matter? A population-based cohort studyA Lustman, S Nakar, A D Cohen and S Vinker Prostate Cancer Prostatic Dis 2014 17: 6-9; advance online publication, September 24, 2013; 10.1038/pcan.2013.34 Abstract | Full Text |  |  |  | EP2 signaling mediates suppressive effects of celecoxib on androgen receptor expression and cell proliferation in prostate cancerE Kashiwagi, M Shiota, A Yokomizo, J Inokuchi, T Uchiumi and S Naito Prostate Cancer Prostatic Dis 2014 17: 10-17; advance online publication, November 26, 2013; 10.1038/pcan.2013.53 Abstract | Full Text |  |  |  | Overexpression of O-GlcNAc by prostate cancer cells is significantly associated with poor prognosis of patientsT Kamigaito, T Okaneya, M Kawakubo, H Shimojo, O Nishizawa and J Nakayama Prostate Cancer Prostatic Dis 2014 17: 18-22; advance online publication, December 24, 2013; 10.1038/pcan.2013.56 Abstract | Full Text |  |  |  | Successful whole-exome sequencing from a prostate cancer bone metastasis biopsyE M Van Allen, A Foye, N Wagle, W Kim, S L Carter, A McKenna, J P Simko, L A Garraway and P G Febbo Prostate Cancer Prostatic Dis 2014 17: 23-27; advance online publication, December 24, 2013; 10.1038/pcan.2013.37 Abstract | Full Text |  |  |  | The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancerC J Paller, D Olatoye, S Xie, X Zhou, S R Denmeade, M A Eisenberger, E S Antonarakis, M A Carducci and G L Rosner Prostate Cancer Prostatic Dis 2014 17: 28-33; advance online publication, October 8, 2013; 10.1038/pcan.2013.40 Abstract | Full Text |  |  |  | Exploratory analysis of the visceral disease subgroup in a phase III study of abiraterone acetate in metastatic castration-resistant prostate cancer OPENO B Goodman, Jr, T W Flaig, A Molina, P F A Mulders, K Fizazi, H Suttmann, J Li, T Kheoh, J S de Bono and H I Scher Prostate Cancer Prostatic Dis 2014 17: 34-39; advance online publication, October 1, 2013; 10.1038/pcan.2013.41 Abstract | Full Text |  |  |  | Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standardM Abd-Alazeez, A Kirkham, H U Ahmed, M Arya, E Anastasiadis, S C Charman, A Freeman and M Emberton Prostate Cancer Prostatic Dis 2014 17: 40-46; advance online publication, October 15, 2013; 10.1038/pcan.2013.43 Abstract | Full Text |  |  |  | Predicting utility scores for prostate cancer: mapping the Prostate Cancer Index to the Patient-Oriented Prostate Utility Scale (PORPUS)K E Bremner, N Mitsakakis, L Wilson and M D Krahn Prostate Cancer Prostatic Dis 2014 17: 47-56; advance online publication, October 15, 2013; 10.1038/pcan.2013.44 Abstract | Full Text |  |  |  | Very-high-risk localized prostate cancer: definition and outcomesD Sundi, V M Wang, P M Pierorazio, M Han, T J Bivalacqua, M W Ball, E S Antonarakis, A W Partin, E M Schaeffer and A E Ross Prostate Cancer Prostatic Dis 2014 17: 57-63; advance online publication, November 5, 2013; 10.1038/pcan.2013.46 Abstract | Full Text |  |  |  | A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomyA E Ross, F Y Feng, M Ghadessi, N Erho, A Crisan, C Buerki, D Sundi, A P Mitra, I A Vergara, D J S Thompson, T J Triche, E Davicioni, E J Bergstralh, R B Jenkins, R J Karnes and E M Schaeffer Prostate Cancer Prostatic Dis 2014 17: 64-69; advance online publication, October 22, 2013; 10.1038/pcan.2013.49 Abstract | Full Text |  |  |  | [-2]proPSA is an early marker for prostate cancer aggressivenessI Heidegger, H Klocker, E Steiner, V Skradski, M Ladurner, R Pichler, G Schäfer, W Horninger and J Bektic Prostate Cancer Prostatic Dis 2014 17: 70-74; advance online publication, October 29, 2013; 10.1038/pcan.2013.50 Abstract | Full Text |  |  |  | Anterior tumors of the prostate: clinicopathological features and outcomesJ Mygatt, I Sesterhenn, I Rosner, Y Chen, J Cullen, T Morris-Gore, J Barton, A Dobi, S Srivastava, D McLeod and S A Brassell Prostate Cancer Prostatic Dis 2014 17: 75-80; advance online publication, December 3, 2013; 10.1038/pcan.2013.54 Abstract | Full Text |  |  |  | An expression signature at diagnosis to estimate prostate cancer patients’ overall survival OPENZ Peng, L Skoog, H Hellborg, G Jonstam, I-L Wingmo, M Hjälm-Eriksson, U Harmenberg, G C Cedermark, K Andersson, L Ährlund-Richter, S Pramana, Y Pawitan, M Nistér, S Nilsson and C Li Prostate Cancer Prostatic Dis 2014 17: 81-90; advance online publication, January 7, 2014; 10.1038/pcan.2013.57 Abstract | Full Text |  |  |  | Predicting bone scan positivity after biochemical recurrence following radical prostatectomy in both hormone-naive men and patients receiving androgen-deprivation therapy: results from the SEARCH databaseD M Moreira, M R Cooperberg, L E Howard, W J Aronson, C J Kane, M K Terris, C L Amling, M Kuchibhatla and S J Freedland Prostate Cancer Prostatic Dis 2014 17: 91-96; advance online publication, January 14, 2014; 10.1038/pcan.2013.59 Abstract | Full Text |  | Corrigendum | Top |  | Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasiaJ M Devaney, S Wang, S Funda, J Long, D J Taghipour, R Tbaishat, P Furbert-Harris, M Ittmann and B Kwabi-Addo Prostate Cancer Prostatic Dis 2014 17: 97; 10.1038/pcan.2013.58 Full Text |  | Erratum | Top |  | Predicting utility scores for prostate cancer: mapping the Prostate Cancer Index to the Patient-Oriented Prostate Utility Scale (PORPUS)K E Bremner, N Mitsakakis, L Wilson and M D Krahn Prostate Cancer Prostatic Dis 2014 17: 98-104; 10.1038/pcan.2013.55 Full Text |  |  |  |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  | |  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Prostate Cancer and Prostatic Diseases. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | | | |
No comments:
Post a Comment